The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 trial of IO102-IO103 and nivolumab-relatlimab fixed-dose combination in previously untreated, unresectable melanoma.
 
James William Smithy
Research Funding - IO Biotech
 
Parisa Momtaz
No Relationships to Disclose
 
Alexander Noor Shoushtari
Consulting or Advisory Role - Bristol-Myers Squibb; Erasca, Inc; Novartis
Research Funding - Alkermes (Inst); Bristol-Myers Squibb; Checkmate Pharmaceuticals (Inst); Foghorn Therapeutics (Inst); Immunocore; Iovance Biotherapeutics (Inst); Linnaeus Therapeutics (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Targovax (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
 
Jeeban Paul Das
No Relationships to Disclose
 
Cecilia Lezcano
Research Funding - ImaginAb
 
Suresh Nair
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst); Mirati Therapeutics (Inst); Nektar (Inst); Strata Oncology (Inst)
 
Sarah E. Lochrin
Travel, Accommodations, Expenses - Novartis
 
Monica F Chen
Stock and Other Ownership Interests - docs; FIGS; Nordisk; Quest Diagnostics
Research Funding - ASCO; NIH
Travel, Accommodations, Expenses - AACR; ASCO
 
Katherine Panageas
Stock and Other Ownership Interests - 23andMe; Adicet Bio; Chinook Therapeutics; Codexis; T2 Biosystems; Vincerx Pharma
Research Funding - AACR (Inst)
Travel, Accommodations, Expenses - The Robert A. Winn Diversity in Clinical Trials Award Program (Winn Awards) in collaboration with the American Association for Cancer Research (AACR), Bristol Myers Squibb Foundation
 
Michael A. Postow
Consulting or Advisory Role - Bristol-Myers Squibb; Cancer Expert Now; Chugai Pharma; Eisai; Erasca, Inc; Intellisphere; Merck; MJH Associates; Nektar; Novartis; Pfizer; WebMD
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Infinity Pharmaceuticals (Inst); Merck (Inst); Novartis (Inst); Rgenix (Inst)